TicoVac Junior 0.25ml pre-filled syringe/Tick-Borne Encephalitis Vaccine (Whole Virus, inactivated) Malta - English - Medicines Authority

ticovac junior 0.25ml pre-filled syringe/tick-borne encephalitis vaccine (whole virus, inactivated)

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - tick, borne encephalitis, virus - suspension for injection - tick-borne encephalitis virus 1,2 - vaccines

TicoVac 0.5ml pre-filled syringe/Tick-Borne Encephalitis Vaccine (Whole Virus, inactivated) Malta - English - Medicines Authority

ticovac 0.5ml pre-filled syringe/tick-borne encephalitis vaccine (whole virus, inactivated)

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - tick, borne encephalitis, virus - suspension for injection in pre-filled syringe - tick-borne encephalitis virus 1,2 0.5 ml - vaccines

TicoVac Junior 0.25 ml Suspension for injection in a pre-filled syringeTick-Borne Encephalitis Vaccine (whole Virus, inactivated) Ireland - English - HPRA (Health Products Regulatory Authority)

ticovac junior 0.25 ml suspension for injection in a pre-filled syringetick-borne encephalitis vaccine (whole virus, inactivated)

pfizer healthcare ireland - tick-borne encephalitis virus (inactivated) neudoerfl - suspension for injection in pre-filled syringe - 0.25 millilitre(s) - encephalitis vaccines; encephalitis, tick borne, inactivated, whole virus - encephalitis vaccines - it is indicated for the active (prophylactic) immunization of children aged from 1 year to 15 years against tick-borne encephalitis (tbe).

TicoVac 0.5 ml Suspension for injection in a pre-filled syringeTick-Borne Encephalitis Vaccine (whole Virus, inactivated) Ireland - English - HPRA (Health Products Regulatory Authority)

ticovac 0.5 ml suspension for injection in a pre-filled syringetick-borne encephalitis vaccine (whole virus, inactivated)

pfizer healthcare ireland - tbe virus antigen - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - encephalitis vaccines; encephalitis, tick borne, inactivated, whole virus - encephalitis vaccines - it is indicated for the active (prophylactic) immunization of persons of 16 years of age and older against tick-borne encephalitis (tbe).

TICOVAC 0.5 ML Israel - English - Ministry of Health

ticovac 0.5 ml

pfizer pharmaceuticals israel ltd - encephalitis, tick borne, inactivated, whole virus - suspension for injection - encephalitis, tick borne, inactivated, whole virus 2.4 mcg / 0.5 ml - encephalitis, tick borne, inactivated, whole virus - ticovac 0.5 ml is indicated for the active (prophylactic) immunization of adolescents from 16 years of age and adults against tick-borne encephalitis (tbe).

TICOVAC JUNIOR 0.25 ML Israel - English - Ministry of Health

ticovac junior 0.25 ml

pfizer pharmaceuticals israel ltd - encephalitis, tick borne, inactivated, whole virus - suspension for injection - encephalitis, tick borne, inactivated, whole virus 1.2 mcg / 0.25 ml - encephalitis, tick borne, inactivated, whole virus - ticovac junior 0.25 ml is indicated for the active (prophylactic) immunization of children aged from 1 year to 15 years against tick-borne encephalitis (tbe).

TICOVAC- tick-borne encephalitis vaccine injection United States - English - NLM (National Library of Medicine)

ticovac- tick-borne encephalitis vaccine injection

pfizer laboratories div pfizer inc - tick-borne encephalitis purified antigen (formaldehyde inactivated) (unii: 42xd79uqq6) (tick-borne encephalitis purified antigen (formaldehyde inactivated) - unii:42xd79uqq6) - ticovac™ is indicated for active immunization to prevent tick-borne encephalitis (tbe). ticovac is approved for use in individuals 1 year of age and older. severe allergic reaction (e.g. anaphylaxis) to any component of ticovac [see description (11)]. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. there are no adequate and well-controlled studies of ticovac in pregnant women. available human data are insufficient to establish the presence or absence of vaccine-associated risk during pregnancy. developmental and reproductive toxicity studies in animals have not been conducted with ticovac. risk summary human data are not available to assess the impact of ticovac on milk production, its presence in breast milk, or its effects on the breastfed. the developmental and health benefits of breastfee

Fsme-Immun 0,5 ml Suspension for injection in pre-filled syringe Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fsme-immun 0,5 ml suspension for injection in pre-filled syringe

pfizer - tick-borne meningoencephalitis virus (tbe) - suspension for injection in pre-filled syringe - 0,5 ml - tick-borne meningoencephalitis virus (tbe) - encephalitis, tick borne, inactivated, whole virus

Fsme-Immun 0,25 ml Junior Suspension for injection in pre-filled syringe Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fsme-immun 0,25 ml junior suspension for injection in pre-filled syringe

pfizer - tick-borne meningoencephalitis virus (tbe) - suspension for injection in pre-filled syringe - tick-borne meningoencephalitis virus (tbe) - encephalitis, tick borne, inactivated, whole virus

Fsme-Immun 0,5 ml inj. susp. i.m./s.c. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fsme-immun 0,5 ml inj. susp. i.m./s.c. pre-filled syr.

pfizer sa-nv - tick-borne encephalitis virus (inactivated) antigen - suspension for injection in pre-filled syringe - 0,5 ml - tick-borne meningoencephalitis virus (tbe) - encephalitis, tick borne, inactivated, whole virus